Enhanced Na-Li countertransport: A marker of inherited susceptibility to type 2 diabetes

International Journal of Epidemiology

Volumn 34, Issue 5, 2005, Pages 1123-1128

  Vaccaro, Olga ^a   Cuomo, Vincenzo ^a   Trevisan, Maurizio ^b   Cirillo, Massimo ^c   Panarelli, Walter ^d   Laurenzi, Martino ^e   Mancini, Mario ^a   Riccardi, Gabriele ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY AT BUFFALO   (United States)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d Gubbio Hospital   (Italy)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Countertransport; Hypertension; Insulin resistance

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LITHIUM; ORAL ANTIDIABETIC AGENT; SODIUM;

HEALTH AND DISEASE;

ADULT; AGED; ANION EXCHANGE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; DIABETIC HYPERTENSION; DIET THERAPY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLLOW UP; GENETIC ANALYSIS; GENETIC RISK; GENETIC SUSCEPTIBILITY; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SODIUM TRANSPORT; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANTIPORTERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; LITHIUM; MALE; MIDDLE AGED; OBESITY; SODIUM;

EID: 27544435751     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyi160     Document Type: Article

References (37)

1. West IC, Rutherford PA, Thomas TH. Sodium lithium countertransport: physiology and function. J Hypertens 1998;16:3-13.
2. Canessa M, Adragna W, Solomon HS, Connolly T, Tosteson DC. Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 1980;302:772-76.
3. Tepper T, Sluiter WJ, Huisman RM, de Zeeuw D. Erythrocyte Na/Li countertransport and Na/K-2Cl cotransport measurement in essential hypertension: Useful diagnostic tools or failure? A metanalysis of 17 years of literature. Clin Sci 1998;95:649-57.
4. Hunt S, Stephenson SH, Hopkins PN, Hassedt SJ, Williams RR. A prospective study of sodium-lithium countertransport and hypertension in Utah. Hypertension 1991;17:1-7.
5. Laurenzi M, Cirillo M, Panarelli W et al. Baseline sodium-lithium countertransport and 6-year incidence of hypertension. The Gubbio population study. Circulation 1997;95:581-87.
6. Strazzullo P, Siani A, Cappuccio FP et al. Red blood cell sodium-lithium countertransport and risk of future hypertension. The Olivetti prospective study. Hypertension 1998;31:1284-89.
7. Dadone MM, Hasstedt SJ, Hunt SC, Smith JB, Ash KO, Williams RR. Genetic analysis of sodium-lithium countertransport in 10 hypertension prone kindred. Am J Med Genet 1984;17:565-77.
8. Williams R, Hasstedt SJ, Hunt SC et al. Genetic traits related to hypertension and electrolite metabolism. Hypertension 1984;17: 69-73.
9. Hasstedt SJ, Wu LL, Ash KO, Kuida H, Williams RR. Hypertension and Sodium lithium countertrasport in Utah pedigrees: Evidence for major locus inheritance. Am J Hum Genet 1988;43:14-22.
10. Rebbeck TR, Turner ST, Michels VV, Moll PP. Genetic and environmental explanations for the distribution of sodium-lithium counter-transport in pedigrees from Rochester, MN. Am J Hum Genet 1991;48:1092-104.
11. Kammerer CM, Cox LA, Mahaney MC, Rogers J, Shade RE. Sodium-lithium countertransport activity is linked to chromosome 5 in baboons. Hypertension 2001;37:398-40.
12. Vaccaro O, Rivellese A, Riccardi G et al. Impaired glucose tolerance and risk factors for atherosclerosis. Arteriosclerosis 1984;4:592-97.
13. Vaccaro O, Imperatore G, Iovino V, Iovine C, Rivellese AA, Riccardi G. Does impaired glucose tolerance predict hypertension? A prospective analysis. Diabetologia 1996;39:70-76.
14. Van Norren K, Thien T, Berden JH, Elving LD, De Pont JJ. Relevance of erythrocyte Na/Li countertransport measurements in essential hypertension, hyperlipidemia and diabetic nephropathy: A critical review. Eur J Clin Invest 1998;28:339-52.
15. + exchange activity. Proc Natl Acad Sci USA 1994;91:5898-902.
16. + antiporter as a candidate gene in human essential hypertension. Hypertension 1991;17:8-14.
17. Zerbini GP, Maestroni A, Breviario D, Mangili R, Casari G. Alternative splicing of NHE-1 mediates Na-Li countertransport and associates with activity rate. Diabetes 2003;52:1511-18.
18. Laurenzi M, Cirillo M, Angeletti M et al. Gubbio population study. Baseline findings. Nutr Metab Cardiovasc Dis 1991;1:S1-S18.
19. Trevisan M, Canessa M, Di Muro MR et al. Outward Na-K-Cl cotransport in human red blood cells; a methodological evaluation of a method for epidemiologic investigation. Am J Epidemiol 1987;125:860-68.
20. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO consultation. Geneva: World Health Organisation, 1999.
21. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in the U.S. population aged 20-74 years. Diabetes 1987;36: 523-34.
22. Monciotti CG, Semplicini A, Morocutti A et al. Elevated sodium lithium countertransport activity in erythrocyte is predictive of the development of microalbuminuria in IDDM. Diabetologia 1997;40:654-61.
23. Trevisan M, Vaccaro O, Laurenzi M. Hypertension, non-insulin dependent diabetes and intracellular sodium metabolism. Hypertension 1988;11:264-68.
24. Gall MA, Rossing P, Jensen JS, Funder J, Parving HH. Red cell Na-Li countertransport in non-insulin-dependent diabetes with diabetic nephropathy. Kidney Int 1991;39:135-40.
25. Pinkey GH, Foyle WJ, Denver AE, Mohamed-Ali V, McKinlay S, Yudkin JS. The relationship of urinary albumin excretion to ambulatory blood pressure and erythrocyte sodium lithium counter-transport in NIDDM. Diabetologia 1995;38:356-62.
26. Mead P, Wilkinson R, Thomas T. Na/Li countertransport abnormalities in type 1 diabetes with and without nephropathy are familial. Diabetes Care 2001;24:527-32.
27. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of diabetes mellitus. J Clin Invest 1999;104:787-94.
28. Giordano M, Castellino P, Solini A, Canessa ML, De Fronzo RA. Na/Li and Na/H countertransport activity in hypertensive noninsulin-dependent diabetic patients: Role of insulin resistance and antihypertensive treatment. Metabolism 1997;46:1316-23.
29. Doria A, Fioretto P, Avogaro A et al. Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension. Am J Physiol 1991;261:684-91.
30. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
31. Thomas TH, Rutherford PA, Vareesangthip K, Wilkinson R, West IC. Erythrocyte membrane thiol proteins associated with changes in the kinetics of Na/Li countertransport: A possible molecular explanation of changes in disease. Eur J Clin Invest 1998;28:259-65.
32. Mead P, Wilkinson R, Thomas TH. Thiol protein defect in sodium lithium countertransport in subset of essential hypertension. Hypertension 1999;34:1275-80.
33. Senior PA, Thomas TH, Marshall SM. Abnormal thiol group modulation of sodium-lithium countertransport and membrane fluidity is associated with a disturbed relationship between serum triacylglycerols and membrane function in type 2 diabetes. Clin Sci 2000;98:673-80.
34. Vessby B, Uusitupa M, Hermansen K et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study. Diabetologia 2001;44:312-19.
35. + countertransport in essential hypertension: Correlation with membrane lipids levels. J Hypertens 1996:14:969-73.
36. Muriana FJ, Villar J, Ruiz-Gutierrez V. Erythrocyte membrane cholesterol distribution in patients with untreated essential hypertension: correlation with sodium-lithium countertransport. J Hypertens 1996;14:443-46.
37. Resnik LM. Ionic basis of hypertension, insulin resistance, vascular disease and related disorders - The mechanism of 'Syndrome X'. Am J Hypertens 1993;6:123S-134S.